APA

Mulvihill E. E., Allister E. M., Sutherland B. G., Telford D. E., Sawyez C. G., Edwards J. Y., Markle J. M., Hegele R. A. & Huff M. W. (20091023). Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. : Diabetes.

Chicago

Mulvihill Erin E, Allister Emma M, Sutherland Brian G, Telford Dawn E, Sawyez Cynthia G, Edwards Jane Y, Markle Janet M, Hegele Robert A and Huff Murray W. 20091023. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. : Diabetes.

Harvard

Mulvihill E. E., Allister E. M., Sutherland B. G., Telford D. E., Sawyez C. G., Edwards J. Y., Markle J. M., Hegele R. A. and Huff M. W. (20091023). Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. : Diabetes.

MLA

Mulvihill Erin E, Allister Emma M, Sutherland Brian G, Telford Dawn E, Sawyez Cynthia G, Edwards Jane Y, Markle Janet M, Hegele Robert A and Huff Murray W. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. : Diabetes. 20091023.